The usefulness of a filtration membrane (Soft Micro Pore Filter (S-MPF) for isolating novel rare cells in peripheral blood circulation tumor cell extraction is examined.
Conditions
Interventions
None listed
Sponsors
kawanishi City Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) The patient has been diagnosed with a malignant tumor with a strong probability of clinical diagnosis. 2) The age of registration must be at least 20 years old and not more than 100 years old. 3) ECOG performance status is 0 or 1. 4) The test result must be completed within 30 days prior to the date of registration, and all of the following must be satisfied. WBC>3,000/mm3, <12,000/mm3 Hb>9.0g/dl Platelet count> 10x104 /mm3 AST<100IU/L, ALT<100IU/L Total bilirubin< 1.5mg/dL Serum creatinine< 2.0mg/dL 5) Cases in which the patient's consent to participate in this study has been obtained in writing
Exclusion criteria
Exclusion criteria: 1) Have an infectious disease that requires systemic treatment, including HIV, HBV, or HCV infection. 2) Have a fever of 38 centi-degrees or higher in axillary temperature within 24 hours prior to enrollment without the use of antipyretics. 3) Cases judged by the attending physician to be inappropriate for conducting this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary endpoint: Frequency of detection of circulating carcinoma cells in the blood by the S-MPF method | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoint: Association between circulating cancer cells and pathology | — |
Countries
Japan
Contacts
Public ContactNoriyoshi Sawabata
Kawanishi City Medical Cent General Thoracic Surgery
Outcome results
None listed